Abstract:Abstract We investigated the association of CYP2A6 genotype with lung cancer risk among African American smokers to further our understanding of cancer susceptibility within this high-risk population. CYP2A6 gene variants are hypothesized to modify lung cancer risk among cigarette smokers by influencing smoking amount, through altered nicotine inactivation, and/or by influencing the bioactivation of carcinogenic tobacco-specific nitrosamines. Participants were African American smokers drawn from two independent lung cancer case-control studies: a study nested within the Southern Community Cohort Study, Vanderbilt University, Nashville, TN with 1-2 controls matched to each incident lung cancer case by age, sex and recruitment site (SCCS: n = 494), and a case-control study from the University of Texas MD Anderson Cancer Center, Houston, TX with controls frequency matched to cases by smoking history in addition to age and sex (MDA: n = 407). Genotyping was performed for 12 CYP2A6 reduced/null activity alleles, and participants with genotypes associated with a 25% or more reduction in CYP2A6 activity were pooled together as reduced metabolizers. Lung cancer risk was estimated through logistic regression modeling, which permitted adjustments for smoking. Compared to the CYP2A6 normal metabolism genotype group, the reduced metabolism group was associated with a significant reduction in lung cancer risk in SCCS, MDA, and in the pooled studies (SCCS: Odds ratio [OR] 0.62, 95% confidence interval [CI] 0.43-0.90; MDA: OR 0.66, 95% CI 0.44-0.98; Pooled: OR 0.64, 95% CI 0.49-0.84; ORs adjusted for age and sex). The association remained significant following additional adjustments for cigarettes/day and years of smoking (SCCS: OR 0.58, 95% CI 0.39-0.87; MDA: OR 0.66, 95% CI 0.44-0.99; Pooled: OR 0.62, 95% CI 0.47-0.83). Stratified analyses within the pooled studies revealed a consistent degree of CYP2A6 genetic risk across categories of cigarettes/day (≤10 cig/day: OR 0.65, 95% CI 0.43-0.98; 11-20 cig/day: OR 0.58, 95% CI 0.37-0.91; >20 cig/day: OR 0.64, 95% CI 0.29-1.44) and further assessment of CYP2A6 genotype and lung cancer risk according to smoking duration and current/former smoking status is ongoing. We also noted a significant interaction between CYP2A6 genotype and sex on the risk for lung cancer (SCCS: P=.03; MDA: P=.03; Pooled: P=.003) with a greater effect in men. Additional analyses are underway to explore potential contributing factors to the observed interaction. Genetic variation in CYP2A6 contributes to lung cancer risk among African American smokers, whereby CYP2A6 genotypes associated with reduced metabolic activity confer a lower risk of developing lung cancer. Citation Format: Catherine A. Wassenaar, Yuanqing Ye, Qiuyin Cai, Melinda Aldrich, Joanne Knight, Margaret R. Spitz, Xifeng Wu, William J. Blot, Rachel F. Tyndale. Genetic variation in CYP2A6, a nicotine/nitrosamine metabolism enzyme, influences lung cancer risk in two independent case-control studies of African American smokers. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4149. doi:10.1158/1538-7445.AM2014-4149

Abstract 2758: Genetic Variability in Tobacco-Specific Nitrosamine NNK to NNAL Metabolism

Genetic Variability in the Metabolism of the Tobacco‐specific Nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK) to 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL)

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Genetic Susceptibility of Lung Cancer Associated with Common Variants in the 3 ' Untranslated Regions of the Adenosine Triphosphate-Binding Cassette B1 (abcb1) and Abcc1 Candidate Transporter Genes for Carcinogen Export

Substantial Reduction in Risk of Lung Adenocarcinoma Associated with Genetic Polymorphism in CYP2A13, the Most Active Cytochrome P450 for the Metabolic Activation of Tobacco-Specific Carcinogen NNK.

NNK-induced DNA Damage As Measured by the Comet Assay is a Marker of Lung Cancer Risk

Analysis of urinary tobacco-specific nitrosamine 4- (methylnitrosamino)1-(3-pyridyl)-1- butanol (NNAL) and HPV infection in American women: National health and nutrition examination survey

Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: a case-control study in a Chinese population.

Abstract 4149: Genetic Variation in CYP2A6, a Nicotine/nitrosamine Metabolism Enzyme, Influences Lung Cancer Risk in Two Independent Case-Control Studies of African American Smokers

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Abstract CN14-01: A genome-wide association study identifies variation in nicotine acetylcholine receptors that influence risk for lung cancer and smoking behavior

Genotoxicity Study on Nicotine and Nicotine-Derived Nitrosamine by Accelerator Mass Spectrometry

Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.

The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and Head and Neck Squamous Cancer Cells

Studies on the Association of NAT2 Polymorphism and Lung Cancer Genetic Susceptibility.

Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study

Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK

Associations Between NBS1 Polymorphisms, Haplotypes and Smoking-Related Cancers

The Contribution of Rare and Common Variants in 30 Genes to Risk Nicotine Dependence

A novel four‐gene biomarker for tobacco smoking -induced colorectal cancer progression

Significant Association of ANKK1 and Detection of a Functional Polymorphism with Nicotine Dependence in an African-American Sample